Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ephedra Case-Control Study Supported By NCCAM Advisory Council

This article was originally published in The Tan Sheet

Executive Summary

A motion recommending that NCCAM initiate a "case-control study...among adolescents and young adults using ephedra for performance enhancement" passed the center's National Advisory Council for Complementary & Alternative Medicine by a 7-3 vote

You may also be interested in...



NCCAM on ephedra

NIH center is considering sponsoring a case-control study on adolescents' use of ephedra for weight-loss and/or performance enhancement. Story on p. 9 of 1"The Tan Sheet" March 24, 2003 implied NCCAM would limit research to the herbal's use for performance enhancement...

NCCAM on ephedra

NIH center is considering sponsoring a case-control study on adolescents' use of ephedra for weight-loss and/or performance enhancement. Story on p. 9 of 1"The Tan Sheet" March 24, 2003 implied NCCAM would limit research to the herbal's use for performance enhancement...

NCCAM on ephedra

NIH center is considering sponsoring a case-control study on adolescents' use of ephedra for weight-loss and/or performance enhancement. Story on p. 9 of 1"The Tan Sheet" March 24, 2003 implied NCCAM would limit research to the herbal's use for performance enhancement...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095252

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel